Frontiers in Clinical Drug Research -CNS and Neurological Disorders

View Sample

Frontiers in Clinical Drug Research -CNS and Neurological Disorders

Volume 2

eBook: US $79 Special Offer (PDF + Printed Copy): US $171
Printed Copy: US $131
Library License: US $316
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-60805-776-4 (Print)
ISBN: 978-1-60805-775-7 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080577571130201

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The second volume of this series features eight chapters that cover a variety of topics including:

-Treatment of multiple sclerosis and schizophrenia

-Neurochemistry of tremors

-Relationship between GABA and Alzheimer’s disease therapy

-Relationship between neurological diseases and cancer

-Research on angiogenesis-related blindness

Indexed in: Scopus, EMBASE, EBSCO.

eBook: US $79 Special Offer: US $171 Printed Copy: US $131 Library License: US $316

Frontiers in Clinical Drug Research - CNS and Neurological Disorders covers important advances in the field of drug development with particular focus on research on drugs in advanced stages of development, clinical trials and applications. This Volume published under the editorship of Prof. Atta-ur-Rahman aims at providing readers with an update on contemporary research. The research articles are comprehensive and have been written by an impressive group of authors, most of whom are well known for their own contributions in the field of drug research.

This book should be of significant interest to Ph.D. students and established researchers. I commend the editor, Prof. Atta-ur-Rahman, and all the contributors for this well written volume which highlights the quest for a cure for CNS and Neurological Disorders.

Ferid Murad
(Nobel Prize Physiology and Medicine 1998)
University Professor
Director of the Cell Signaling Institute
George Washington University
Washington, DC, USA